• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2.

作者信息

Miyatake S, Handa H, Yamashita J, Yamasaki T, Ueda M, Namba Y, Hanaoka M

出版信息

J Neurooncol. 1986;4(1):55-64. doi: 10.1007/BF02158003.

DOI:10.1007/BF02158003
PMID:3489081
Abstract

Two human glioma-specific cytotoxic T-lymphocyte (G-S-CTL) lines were established by autologous tumor stimulation (ATS) with the aid of lectin free interleukin 2 (IL 2). Coculture of patient's peripheral blood lymphocytes and autologous irradiated glioma cells and subsequent addition of partially purified IL 2 enhanced the tumoricidal activity of the lymphocytes. These CTL lines possessed cross-cytotoxic activity against autologous allogeneic glioma cells and exhibited low cytotoxic activity against non-glial tumor cells. They did not lyse autologous lymphoblasts. This phenomenon suggested the existence of a common glioma-specific antigen recognized by the CTL lines. T-cell subset depletion test revealed that the major surface phenotype of G-S-CTL line, responsible for cytotoxic activity was OKT 3 positive, OKT 4 negative and OKT 8 positive. G-S-CTL lines were composed of a low proportion of OKT 8 positive subpopulation after primary ATS and successive propagation with IL 2. The proportion of OKT 8 positive subpopulation was increased by secondary ATS, which enhanced the cytotoxic activity to glioma cells more effectively.

摘要

相似文献

1
Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2.
J Neurooncol. 1986;4(1):55-64. doi: 10.1007/BF02158003.
2
Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.肿瘤裂解物和负载白细胞介素-18的树突状细胞在恶性胶质瘤患者中引发Th1反应、肿瘤特异性CD8+细胞毒性T细胞。
J Neurooncol. 2005 Apr;72(2):107-13. doi: 10.1007/s11060-004-3550-9.
3
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.与自体黑色素瘤细胞反应的克隆化人细胞毒性T淋巴细胞(CTL)系。I. 体外生成、分离及表型和特异性分析。
J Immunol. 1984 Jan;132(1):510-9.
4
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.人类转移性黑色素瘤浸润中的自体肿瘤特异性细胞毒性T淋巴细胞。白细胞介素2和自体肿瘤细胞的激活作用以及T细胞受体的参与。
J Exp Med. 1988 Oct 1;168(4):1419-41. doi: 10.1084/jem.168.4.1419.
5
Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.通过交叉反应性同种肿瘤细胞刺激诱导针对自体脑肿瘤的特异性细胞毒性T淋巴细胞。
Jpn J Cancer Res. 1997 Mar;88(3):289-95. doi: 10.1111/j.1349-7006.1997.tb00380.x.
6
Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.利用T细胞生长因子建立实验性恶性胶质瘤特异性细胞毒性T淋巴细胞克隆
J Neurosurg. 1984 May;60(5):998-1004. doi: 10.3171/jns.1984.60.5.0998.
7
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.淋巴因子激活的杀伤细胞现象。II. 前体细胞表型在血清学上与外周T淋巴细胞、记忆性细胞毒性胸腺来源淋巴细胞及自然杀伤细胞不同。
J Exp Med. 1983 Mar 1;157(3):884-97. doi: 10.1084/jem.157.3.884.
8
Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.通过体内预刺激和肿瘤细胞体外二次刺激产生针对大鼠胶质瘤的细胞毒性免疫反应。
Neurosurgery. 1992 Apr;30(4):499-504; discussion 504-5. doi: 10.1227/00006123-199204000-00005.
9
Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.肿瘤信使核糖核酸负载的树突状细胞在恶性胶质瘤患者中引发肿瘤特异性CD8(+) 细胞毒性T细胞。
Cancer Immunol Immunother. 2003 Oct;52(10):632-7. doi: 10.1007/s00262-003-0408-5. Epub 2003 Jun 21.
10
Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.通过皮下接种经辐照的野生型肿瘤细胞,无需人工产生细胞因子,即可有效诱导胶质瘤特异性细胞毒性T细胞。
Int J Oncol. 2003 Aug;23(2):483-8.

引用本文的文献

1
Recent developments on immunotherapy for brain cancer.脑癌免疫治疗的最新进展。
Expert Opin Emerg Drugs. 2012 Jun;17(2):181-202. doi: 10.1517/14728214.2012.679929. Epub 2012 Apr 25.
2
Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.生物疗法:结直肠癌的治疗方法。增强癌胚抗原(CEA)作为免疫原性靶点的策略。
Br J Cancer. 1998 Mar;77(5):683-93. doi: 10.1038/bjc.1998.114.
3
Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

本文引用的文献

1
Human glioma-associated antigens detected by monoclonal antibodies.通过单克隆抗体检测到的人类胶质瘤相关抗原。
Cancer Res. 1981 Mar;41(3):1209-13.
2
Immunological aspects of intrinsic glial tumors.原发性胶质肿瘤的免疫学方面
J Neurosurg. 1981 Jul;55(1):1-18. doi: 10.3171/jns.1981.55.1.0001.
3
Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.原发性颅内肿瘤的免疫生物学。第5部分:淋巴细胞指数与临床状态的相关性。
自体肿瘤细胞疫苗联合过继性细胞免疫疗法治疗Ⅲ/Ⅳ级星形细胞瘤患者
J Neurooncol. 1996 Feb;27(2):179-89. doi: 10.1007/BF00177482.
4
Relevance of the T cell receptor for immunotherapy of cancer.T细胞受体在癌症免疫治疗中的相关性。
Cancer Immunol Immunother. 1994 Jul;39(1):1-14. doi: 10.1007/BF01517174.
5
Human interleukin-2 activated cytotoxic cells kill autologous glioma cells in vitro.人白细胞介素-2激活的细胞毒性细胞在体外可杀伤自体胶质瘤细胞。
J Neurooncol. 1988;6(1):85-92. doi: 10.1007/BF00163545.
J Neurosurg. 1981 Mar;54(3):331-7. doi: 10.3171/jns.1981.54.3.0331.
4
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.术后放疗与亚硝基脲类药物治疗恶性胶质瘤的随机对照比较。
N Engl J Med. 1980 Dec 4;303(23):1323-9. doi: 10.1056/NEJM198012043032303.
5
Immunobiologic aspects of the brain and human gliomas. A review.大脑与人类胶质瘤的免疫生物学方面。综述
Am J Pathol. 1980 Feb;98(2):517-68.
6
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.通过白细胞介素-2扩增的淋巴细胞进行全身转移,使播散性同基因实体瘤消退。
J Exp Med. 1982 Aug 1;156(2):385-97. doi: 10.1084/jem.156.2.385.
7
Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.采用在体内和体外依次免疫并用白细胞介素2培养进行非特异性扩增的同基因淋巴细胞对已确诊的白血病进行特异性过继性治疗。
J Immunol. 1981 Apr;126(4):1318-22.
8
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.从植物血凝素刺激的淋巴细胞条件培养基中纯化人T细胞生长因子及其某些特性
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6134-8. doi: 10.1073/pnas.77.10.6134.
9
Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.人类胸腺内分化的离散阶段:T细胞系正常胸腺细胞和白血病淋巴母细胞的分析
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588-92. doi: 10.1073/pnas.77.3.1588.
10
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.人类恶性黑色素瘤的细胞表面抗原:用小鼠单克隆抗体对六种抗原系统的定义
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114-8. doi: 10.1073/pnas.77.10.6114.